iTeos Therapeutics, Inc.·4

Aug 5, 7:55 PM ET

Call Matthew 4

4 · iTeos Therapeutics, Inc. · Filed Aug 5, 2021

Insider Transaction Report

Form 4
Period: 2021-07-30
Call Matthew
Chief Operating Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2021-07-30$2.95/sh+53,672$158,33253,672 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-07-3053,672148,090 total
    Exercise: $2.95Exp: 2029-12-04Common Stock (53,672 underlying)
Footnotes (1)
  • [F1]One-fourth of the shares subject to the stock option vest on the one-year anniversary of the vesting commencement date. Thereafter, 1/48 of the shares subject to the stock option vest on a monthly basis following the one-year anniversary of the vesting commencement date, subject to the reporting person's continuous service relationship with the Issuer through each applicable vesting date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION